CACNA1S

Chr 1ADAR

calcium voltage-gated channel subunit alpha1 S

Also known as: CACNL1A3, CCHL1A3, CMYO18, CMYP18, Cav1.1, DHPRM, HOKPP, HOKPP1

The protein forms the pore-forming alpha-1S subunit of L-type voltage-gated calcium channels in skeletal muscle and plays a critical role in excitation-contraction coupling by interacting with RYR1 to trigger calcium release from the sarcoplasmic reticulum. Mutations cause hypokalemic periodic paralysis, thyrotoxic periodic paralysis, and malignant hyperthermia susceptibility, following an autosomal dominant inheritance pattern. The gene is extremely intolerant to loss-of-function variants (pLI near 1.0), indicating that such mutations are likely highly deleterious.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismAD/ARLOEUF 0.524 OMIM phenotypes
Clinical SummaryCACNA1S
🧬
Gene-Disease Validity (ClinGen)
malignant hyperthermia, susceptibility to, 5 · ADModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
4 unique Pathogenic / Likely Pathogenic· 119 VUS of 200 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.52LOEUF
pLI 0.000
Z-score 5.36
OE 0.39 (0.300.52)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
-0.11Z-score
OE missense 1.01 (0.961.06)
1075 obs / 1064.8 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.39 (0.300.52)
00.351.4
Missense OE1.01 (0.961.06)
00.61.4
Synonymous OE1.10
01.21.6
LoF obs/exp: 36 / 91.3Missense obs/exp: 1075 / 1064.8Syn Z: -1.67
DN
0.81top 10%
GOF
0.83top 10%
LOF
0.2190th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

200 submitted variants in ClinVar

Classification Summary

Pathogenic2
Likely Pathogenic2
VUS119
Likely Benign69
Benign1
Conflicting7
2
Pathogenic
2
Likely Pathogenic
119
VUS
69
Likely Benign
1
Benign
7
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
2
0
0
0
2
Likely Pathogenic
2
0
0
0
2
VUS
5
100
13
1
119
Likely Benign
0
2
21
46
69
Benign
0
1
0
0
1
Conflicting
7
Total91033447200

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CACNA1S · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →